|Basis of Allotment|
SMS PHARMACEUTICALS LIMITED
(Our Company was incorporated as S.M.S. Pharmaceuticals Private Umitad,
on December 14,1987 under the Companies Act 1956. Subsequently our company became a public
United Company and the name was changed to S.M.S. Pharmaceuticals Limited on Novembers
1994. Subsequently on April 12, 2004 our Company was renamed as SMS Pharmaceuticals
BASIS OF ALLOTMENT
ISSUE OF 2,577,000 EQUITY SHARES OF RS. 10/- EACH FOR CASH AT A PRICE OF RS. 380 PER EQUITY SHARE (INCLUDING SHARE PREMIUM OF RS. 370 PER SHARE) AGGREGATING RS. 979.26 MILLION BY SMS PHARMACEUTICALS UMITED ("SMS" OR "THE COMPANY" OR "THE ISSUER"). THE ISSUE COMPRISES OF "NET ISSUE TO THE PUBLIC" OF 2,577,000 EQUITY SHARES AGGREGATING RS. 979.26 MILLION. THE NET ISSUE TO THE PUBLIC WOULD CONSTITUTE 25.77% OF THE FULLY DILUTED POST ISSUE PAID UP CAPITAL OF THE COMPANY.
The Issue made through the 100% Book Building Process wherein not more than 50% of the Issue to the public was to be allocated on a proportionate basis to Qualified institutional Buyers ("QIBs") (including 5% of the QIB portion that was to specifically be allotted to mutual funds)., Further, not less than 15% of the Net Issue to the public shall be available for allocation on a proportionate basis to Non-Institutional Bidders and not less than 35% of the Net Issue to the public shall be available tor allocation on a proportionate basis to Retail Bidders, subject to valid bids being received at or above the Issue Price.
The Issue received 24,244 applications for 65,83,370 equity shares resulting In 2.55 times subscription.
The Basis of Allotment for all the categories namely Retail Individual Investors, Non Institutional Investors and Qualified Institutional Buyers was approved by Bombay Stock Exchange Limited (Designated Stock Exchange) on February 21,2007. The Board of Directors of the Company at its Meeting held at Hyderabad, on February 22,2007, allotted the Equity Shares to the successful applicants. Details of valid applications received and allotments done are as under:
2,225 excess equity shares have been allotted In Retail category due to rounding off.
A. Allotment to Retail investors (After Technical Rejections)
B. Allotment to Non institutional Investors (After Technical Rejections)
All the bidders in the Non Institutional Category, who have bid at the Issue Price of
Rs 380/- per Equity Share, have been considered while preparing the basis of allotment.
The category was undersubscribed. The total number of shares allotted in this category is
63,105 Equity Shares.
C. Allotment to QIBs
The total number of Equity Shares allotted In this category are 12,88,500 Equity Shares (50% of total Equity Shares allotted). All the applicants In this category have been given Firm Allotment on a PROPORTIONATE BASIS.
Refunds have been made through ECS, Direct credit, RTGS and NEFT, Into
the Bank Accounts of the applicants, as registered with the depositories, for applicants
residing at any of the 15 centres specified by SEBI, For other applicants Refund Orders
have been despatched to their address as registered with the depositories. In case the
same is not received within ten days, applicants may contact at the address given below.
ECS Intimation Note and Refund Orders have been over-printed with the Bank Mandate details
as registered, if any, with the depositories. The Equity Shares allotted to successful
applicants have been credited to their beneficiary accounts.
This details of the allotment mads would be hosted on the website of Registrars
to the Issue, Aarthl Consultants Private Limited at www.aarthiconsultants.com.
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY 8HARE ON LISTING OR THE BUSINESS PROSPECTS OF SMS PHARMACEUTICALS LIMITED.